TrialStem cell research & therapy2025

A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjögren's and Sjögren's syndrome dry eye disease.

Di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.